Investing in Mirati Therapeutics, Inc.? If so, we recommend checking out these offers as well (we believe these to be much more interesting):
Cannabis Trader: https://logistics-business-review.com/cannabis-trader-for-MRTX-investors
Trade Netflix: https://logistics-business-review.com/netflix-for-MRTX-investors
Wall Street Journal: https://logistics-business-review.com/wsj-for-MRTX-investors (only $12 for 12 weeks – everyone should get this)
REPORTING FOR 2019-07-29 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how Mirati Therapeutics, Inc. ($MRTX) has been trading over the last 2 weeks and the past day especially. On its latest session, Mirati Therapeutics, Inc. ($MRTX) opened at 96.9, reaching a high of 99.06 and a low of 95.46 before closing at a price of 98.65. There was a total volume of 372289.
VOLUME INDICATORS: We saw an accumulation-distribution index of 2039.60208, an on-balance volume of 97.15, chaikin money flow of 2.33333 and a force index of 1.4279. There was an ease of movement rating of -0.00662, a volume-price trend of 19.06933 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 2.57681, bolinger bands of 98.42703, an upper bollinger band of 94.04297, lower bollinger band of 95.46, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 97.14, high band keltner channel of 94.98, low band keltner channel of 99.3, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 95.46, a donchian channel low band of 95.46, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.03478, a MACD signal of 0.01932, a MACD difference of 0.01546, a fast Exponential Moving Average (EMA) indicator of 95.46, a slow Exponential Moving Average (EMA) indicator of 95.46, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.36241, a trix of 11.01007, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of -15.48376, a KST Oscillator (KST) of 193.60449 and a KST Oscillator (KST Signal) of 193.60449 (leaving a KST difference of 4.84519). We also found an Ichimoku rating of 97.98, an Ichimoku B rating of 97.98, a Ichimoku visual trend A of 85.16679, an Ichimoku visual trend B of 90.13599, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 91.49125, a stochastic oscillator of 166.66667, a stochastic oscillator signal of 166.66667, a Williams %R rating of 66.66667 and an awesome oscillator of 0.92717.
RETURNS: There was a daily return of 19.36045, a daily log return of 1.61068 and a cumulative return of 1.62372.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-29 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Mirati Therapeutics, Inc. ($MRTX)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Mirati Therapeutics, Inc., we strongly advise Mirati Therapeutics, Inc. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Mirati Therapeutics, Inc. – without this you are trading blind:
We will of course continue to cover the news and price action of Mirati Therapeutics, Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Mirati Therapeutics, Inc. ($MRTX) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.